title: Humoral immune response limits gene therapy in canine MPS I.
authors.forename: R
authors.initials: R
authors.lastname: Shull
authors.forename: X
authors.initials: X
authors.lastname: Lu
authors.forename: I
authors.initials: I
authors.lastname: Dubé
authors.forename: C
authors.initials: C
authors.lastname: Lutzko
authors.forename: S
authors.initials: S
authors.lastname: Kruth
authors.forename: A
authors.initials: A
authors.lastname: Abrams-Ogg
authors.forename: H P
authors.initials: HP
authors.lastname: Kiem
authors.forename: S
authors.initials: S
authors.lastname: Goehle
authors.forename: F
authors.initials: F
authors.lastname: Schuening
authors.forename: C
authors.initials: C
authors.lastname: Millan
authors.forename: R
authors.initials: R
authors.lastname: Carter
mesh_terms: D000818:Animals; D018076:DNA, Complementary / Q000235:genetics; D004285:Dogs / Q000276:immunology*; D004797:Enzyme-Linked Immunosorbent Assay; D015316:Genetic Therapy; D005822:Genetic Vectors / Q000235:genetics; D007068:Iduronidase / Q000172:deficiency / Q000235:genetics / Q000276:immunology / Q000627:therapeutic use*; D007074:Immunoglobulin G / Q000096:biosynthesis*; D007518:Isoantibodies / Q000096:biosynthesis*; D008059:Mucopolysaccharidosis I / Q000276:immunology / Q000628:therapy*; D011993:Recombinant Fusion Proteins / Q000276:immunology / Q000627:therapeutic use; D012190:Retroviridae / Q000235:genetics
chemical_list: D018076:DNA, Complementary; D007074:Immunoglobulin G; D007518:Isoantibodies; D011993:Recombinant Fusion Proteins; D007068:Iduronidase